Mechanisms of Drug Resistance in Cancer Therapy (eBook, PDF)
Redaktion: Mandalà, Mario; Romano, Emanuela
113,95 €
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
57 °P sammeln
113,95 €
Als Download kaufen
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
57 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
113,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
57 °P sammeln
Mechanisms of Drug Resistance in Cancer Therapy (eBook, PDF)
Redaktion: Mandalà, Mario; Romano, Emanuela
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 7.23MB
Andere Kunden interessierten sich auch für
- Angelika BöttgerLessons on Caffeine, Cannabis & Co (eBook, PDF)57,95 €
- Molecular and Therapeutic actions of Thymoquinone (eBook, PDF)73,95 €
- Selenium (eBook, PDF)73,95 €
- Patrick L. IversenMolecular Basis of Resilience (eBook, PDF)113,95 €
- Nanotechnology in Skin, Soft Tissue, and Bone Infections (eBook, PDF)73,95 €
- -29%11Treatment and Prevention of Malaria (eBook, PDF)113,95 €
- Comparative and Veterinary Pharmacology (eBook, PDF)233,95 €
-
-
-
A major objective of this book is to reveal unprecedented opportunities to understand and overcome drug resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive and prognostic biomarkers to enable patient stratification and tailor treatments. It offers to the readers an updated overview on the possible reasons of failure of new and promising therapeutic opportunities.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Seitenzahl: 297
- Erscheinungstermin: 10. Januar 2019
- Englisch
- ISBN-13: 9783030105075
- Artikelnr.: 56815078
- Verlag: Springer International Publishing
- Seitenzahl: 297
- Erscheinungstermin: 10. Januar 2019
- Englisch
- ISBN-13: 9783030105075
- Artikelnr.: 56815078
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm.- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival.- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.- 5. Mechanisms of Drug Resistance in Melanoma.- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies.- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma.- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer.- 9. Targeting DNA repair.- 10. Resistance to Hormonal Therapy in Prostate Cancer.- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors.- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.- 14. Mechanisms of Resistance in Multiple Myeloma.- 15. Cancer Evolution as the New Frontier of Precision.
1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm.- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival.- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.- 5. Mechanisms of Drug Resistance in Melanoma.- 6.Mechanisms of Resistance to Immune Checkpoint Antibodies.- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma.- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer.- 9. Targeting DNA repair.- 10.Resistance to Hormonal Therapy in Prostate Cancer.- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors.- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.- 14. Mechanisms of Resistance in Multiple Myeloma.- 15. Cancer Evolution as the New Frontier of Precision.
1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm.- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival.- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.- 5. Mechanisms of Drug Resistance in Melanoma.- 6. Mechanisms of Resistance to Immune Checkpoint Antibodies.- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma.- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer.- 9. Targeting DNA repair.- 10. Resistance to Hormonal Therapy in Prostate Cancer.- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors.- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.- 14. Mechanisms of Resistance in Multiple Myeloma.- 15. Cancer Evolution as the New Frontier of Precision.
1. Molecular and Pharmacological Mechanisms of Drug Resistance: An Evolving Paradigm.- 2. Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival.- 3. Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.- 4. Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.- 5. Mechanisms of Drug Resistance in Melanoma.- 6.Mechanisms of Resistance to Immune Checkpoint Antibodies.- 7. Immunotolerance as a Mechanism of Resistance to Targeted Therapies in Melanoma.- 8. Plasticity of Resistance and Sensitivity to Anti-Epidermal Growth Factor Receptor Inhibitors in Metastatic Colorectal Cancer.- 9. Targeting DNA repair.- 10.Resistance to Hormonal Therapy in Prostate Cancer.- 11. Mechanism of Resistance in Gastrointestinal Stromal Tumors.- 12. Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.- 13. Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia.- 14. Mechanisms of Resistance in Multiple Myeloma.- 15. Cancer Evolution as the New Frontier of Precision.